 Leap Therapeutics, Inc. Nasdaq: LPTX, a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced changes to the Companys Executive Leadership Team. All changes to the Board of Directors are effective immediately. Other management changes will take effect April 1, 2020, and include the following: 